SIGA Completes Fourth Successful Human Safety Clinical Trial
June 23, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 23, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
Andy Stern Joins SIGA's Board of Directors
June 21, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 21, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
SIGA CEO Dr. Eric Rose Addresses Congressional Appropriations Subcommittee on Behalf of the Alliance for Biosecurity
May 12, 2010 14:54 ET
|
SIGA Technologies Inc.
NEW YORK, May 12, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, today announced that its Chief...
Press Release Correction: SIGA Technologies Reports Operating Results for the First Quarter of 2010
May 04, 2010 19:21 ET
|
SIGA Technologies Inc.
NEW YORK, May 4, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, issued a correction of today's press...
SIGA Technologies Reports Operating Results for the First Quarter of 2010
May 04, 2010 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, May 4, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, today reported its financial results...
SIGA to Discuss First Quarter Results of Operations on May 4, 2010
April 27, 2010 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, April 27, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, announced today...
SIGA Technologies Reports Financial Results for the Fourth Quarter and Full Year of 2009
March 10, 2010 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, March 10, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced...
SIGA to Discuss Fourth Quarter and Year-End 2009 Results of Operations on March 10, 2010
March 05, 2010 12:00 ET
|
SIGA Technologies Inc.
NEW YORK, March 5, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, announced today...
SIGA to Participate at RBC Capital Markets and Cowen & Company Healthcare Conferences
March 01, 2010 14:30 ET
|
SIGA Technologies Inc.
NEW YORK, March 1, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced...
SIGA Awarded a $2.8 Million DoD Contract With Additional Options for the Development of a Broad Spectrum Antiviral Drug
February 25, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, Feb. 25, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced it...